10-Q/A: Healthcare AI Acquisition Corp. Files Amended 10-Q, Citing Material Weaknesses in Financial Controls

Healthcare AI Acquisition Corp. has filed an amended quarterly report citing material weaknesses in financial controls and providing an update on its financial position.

Summary

• Healthcare AI Acquisition Corp. filed an amended 10-Q/A report for the quarter ended March 31, 2024, primarily to post iXBRL files.
• The company reported a net loss of $466,716 for the three months ended March 31, 2024, compared to a net loss of $225,709 for the same period in 2023.
• The company's cash balance remained at $212, while the cash and investments held in the trust account increased to $6,674,018 from $6,588,790 at the end of 2023.
• The company has identified material weaknesses in its disclosure controls and procedures, specifically in the valuation of warrant liabilities and recording of accounts payable and accrued expenses.
• The company's working capital deficit was $680,579 as of March 31, 2024, compared to a deficit of $593,046 as of December 31, 2023.
• The company has until December 14, 2024, to complete a business combination, and there is uncertainty about its ability to do so.
• The company's management has expressed substantial doubt about the company's ability to continue as a going concern for the next twelve months.

Sentiment

Score: 2

Explanation: The document reveals significant financial and operational challenges, including a substantial net loss, material weaknesses in financial controls, and a going concern warning, indicating a very negative outlook.

Positives

• The cash and investments held in the trust account increased slightly to $6,674,018.

Negatives

• The company reported a larger net loss of $466,716 for the quarter ended March 31, 2024, compared to $225,709 for the same period in 2023.
• The company has a working capital deficit of $680,579.
• The company identified material weaknesses in its financial controls.
• Management has expressed substantial doubt about the company's ability to continue as a going concern.

Risks

• The company's ability to complete a business combination by December 14, 2024, is uncertain.
• The company's material weaknesses in financial controls could lead to further issues.
• The company's working capital deficit and limited cash on hand raise concerns about its ability to operate.
• The company may be required to liquidate if a business combination is not completed, resulting in the warrants expiring worthless.

Future Outlook

The company's ability to continue as a going concern is uncertain, and it must complete a business combination by December 14, 2024, or face liquidation.

Management Comments

• Management has determined that mandatory liquidation, and subsequent dissolution, should the Company be unable to complete a business combination, raises substantial doubt about the Company's ability to continue as a going concern for the next twelve months from the issuance of these financial statements.
• Management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the periods presented.

Industry Context

This announcement is typical for a SPAC that is nearing its deadline to complete a business combination. The material weaknesses in financial controls and the going concern warning are concerning and could make it more difficult to find a suitable target.

Comparison to Industry Standards

• The financial performance of Healthcare AI Acquisition Corp. is below average compared to other SPACs, particularly given the significant net loss and the material weaknesses in financial controls.
• Many SPACs have successfully completed business combinations within their allotted timeframes, while Healthcare AI Acquisition Corp. is facing significant challenges in this regard.
• The level of redemptions experienced by Healthcare AI Acquisition Corp. is higher than average, indicating a lack of investor confidence.
• The company's reliance on working capital loans from the sponsor is not uncommon for SPACs, but the uncertainty surrounding the company's ability to continue as a going concern is a significant concern.

Management Changes

Related Party Transactions

• The New Sponsor and New Sponsor's shareholder loaned a total of $51,449 and $65,000 to the Company pursuant to a non-interest bearing and unsecured promissory note that is due upon closing of an initial Business Combination.
• The company has $303,330 borrowings under the New Sponsor's Working Capital Loans as of March 31, 2024.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company fails to complete a business combination.
• Employees may face job insecurity due to the company's uncertain future.
• Creditors face the risk of not being repaid if the company liquidates.

Next Steps

• The company needs to identify and complete a business combination by December 14, 2024.
• The company needs to address the material weaknesses in its financial controls.
• The company needs to secure additional funding to continue operations.

Key Dates

Keywords

SPAC, Business Combination, Financial Controls, Warrant Liabilities, Going Concern, Material Weakness, Redemption, Trust Account, Healthcare AI Acquisition Corp